Vandortuzumab vedotin
Appearance
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | STEAP1 |
Clinical data | |
Other names | RG7450 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C6608H10168N1756O2076S44 |
Molar mass | 156-160 kDa g·mol−1 |
Vandortuzumab vedotin (RG7450) (INN) is a humanized monoclonal antibody designed for the treatment of cancer.[1][2]
This drug was developed by Genentech/Roche.